
Immucell Corp
ICCC
ICCC: ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The firm has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing product line extensions of its existing products that address mastitis. Its lead product, First Defense, is manufactured to prevent scours in newborn calves. It has two segments Scours and Mastitis. The company generates the majority of its revenue from the United States.
moreShow ICCC Financials
Recent trades of ICCC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ICCC's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Methods and systems of producing pharmaceutical grade lantibiotics Jul. 17, 2018
Federal grants, loans, and purchases
Followers on ICCC's company Twitter account
Number of mentions of ICCC in WallStreetBets Daily Discussion
Recent insights relating to ICCC
Recent picks made for ICCC stock on CNBC
ETFs with the largest estimated holdings in ICCC
Flights by private jets registered to ICCC